Cowen and Company’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-250,974
| Closed | -$4.47K | – | 718 |
|
|
2022
Q4 | $4.47K | Hold |
250,974
| – | – | ﹤0.01% | 447 |
|
|
2022
Q3 | $21K | Buy |
250,974
+32,691
| +15% | +$2.74K | ﹤0.01% | 344 |
|
|
2022
Q2 | $17K | Buy |
218,283
+92,233
| +73% | +$7.18K | ﹤0.01% | 356 |
|
|
2022
Q1 | $25K | Buy |
126,050
+37,887
| +43% | +$7.51K | ﹤0.01% | 339 |
|
|
2021
Q4 | $48K | Buy |
88,163
+33,091
| +60% | +$18K | ﹤0.01% | 377 |
|
|
2021
Q3 | $33K | Buy |
+55,072
| New | +$33K | ﹤0.01% | 330 |
|